Compare BIO & IAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | IAG |
|---|---|---|
| Founded | 1952 | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Precious Metals |
| Sector | Industrials | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.5B |
| IPO Year | 1994 | 2002 |
| Metric | BIO | IAG |
|---|---|---|
| Price | $386.11 | $20.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $339.75 | $17.75 |
| AVG Volume (30 Days) | 236.0K | ★ 5.4M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.61 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,583,200,000.00 | N/A |
| Revenue This Year | $2.74 | $44.70 |
| Revenue Next Year | $3.20 | $1.11 |
| P/E Ratio | ★ N/A | $18.66 |
| Revenue Growth | ★ 0.65 | N/A |
| 52 Week Low | $236.73 | $9.86 |
| 52 Week High | $396.23 | $24.87 |
| Indicator | BIO | IAG |
|---|---|---|
| Relative Strength Index (RSI) | 69.94 | 60.85 |
| Support Level | $287.41 | $15.52 |
| Resistance Level | $396.23 | $20.82 |
| Average True Range (ATR) | 11.10 | 0.79 |
| MACD | -0.93 | -0.13 |
| Stochastic Oscillator | 79.56 | 63.59 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Cote Gold mine - Canada, Burkina Faso - Essakane mine, Westwood mine - Canada. The company's s non-gold mine segments are Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Cote Gold mine segment.